Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE NOUFEL SEDDIKI : revenue, balance sheet and financial ratios

SELARL PHARMACIE NOUFEL SEDDIKI is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BAGNOLET (93170), this company of category PME shows in 2023 a net income positive of 85 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE NOUFEL SEDDIKI (SIREN 851427203)
Indicator 2023 2022 2019
Revenue N/C N/C N/C
Net income 84 688 € 95 235 € 24 716 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2023, SELARL PHARMACIE NOUFEL SEDDIKI generates positive net income of 85 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2023: 25 k€ -> 85 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

84 688 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

41.057%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.84%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

56.6%

Solvency indicators evolution
SELARL PHARMACIE NOUFEL SEDDIKI

Sector positioning

Debt ratio
41.06 2023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -39 pts over 3 years

In 2023, the debt ratio of SELARL PHARMACIE NOUFEL S... (41.06) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
52.84% 2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +30 pts over 3 years

In 2023, the financial autonomy of SELARL PHARMACIE NOUFEL S... (52.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 198.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

198.064

Liquidity indicators evolution
SELARL PHARMACIE NOUFEL SEDDIKI

Sector positioning

Liquidity ratio
198.06 2023
2019
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good +14 pts over 3 years

In 2023, the liquidity ratio of SELARL PHARMACIE NOUFEL S... (198.06) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE NOUFEL SEDDIKI in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELARL PHARMACIE NOUFEL SEDDIKI is estimated at 999 274 € (range 607 706€ - 1 404 755€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
607k€ 999k€ 1404k€
999 274 € Range: 607 706€ - 1 404 755€
NAF 5 année 2023

Valuation method used

Net Income Multiple
84 688 € × 11.8x = 999 274 €
Range: 607 706€ - 1 404 755€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE NOUFEL SEDDIKI with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE NOUFEL SEDDIKI

What is the revenue of SELARL PHARMACIE NOUFEL SEDDIKI ?

The revenue of SELARL PHARMACIE NOUFEL SEDDIKI is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE NOUFEL SEDDIKI profitable?

Yes, SELARL PHARMACIE NOUFEL SEDDIKI generated a net profit of 85 k€ in 2023.

Where is the headquarters of SELARL PHARMACIE NOUFEL SEDDIKI ?

The headquarters of SELARL PHARMACIE NOUFEL SEDDIKI is located in BAGNOLET (93170), in the department Seine-Saint-Denis.

Where to find the tax return of SELARL PHARMACIE NOUFEL SEDDIKI ?

The tax return of SELARL PHARMACIE NOUFEL SEDDIKI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE NOUFEL SEDDIKI operate?

SELARL PHARMACIE NOUFEL SEDDIKI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.